Lantern Pharma Inc. Common Stock LTRN
$0.86
-13.99%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-10-01 | View → |
| 8-K | 8-K | 2026-09-30 | View → |
| 424B5 | 424B5 | 2026-09-30 | View → |
| 8-K | 8-K | 2026-09-24 | View → |
| 8-K | 8-K | 2026-09-23 | View → |
| 8-K | 8-K | 2026-08-14 | View → |
| 10-Q | 10-Q | 2026-08-14 | View → |
| 8-K | 8-K | 2026-08-03 | View → |
| S-1 | S-1 | 2026-06-12 | View → |
| 8-K | 8-K | 2026-06-02 | View → |
| 8-K | 8-K | 2026-05-15 | View → |
| 10-Q | 10-Q | 2026-05-15 | View → |
| 8-K | 8-K | 2026-05-14 | View → |
| 4 | 4 | 2026-05-14 | View → |
| 4 | 4 | 2026-05-14 | View → |
| 424B5 | 424B5 | 2026-05-14 | View → |
| 8-K | 8-K | 2026-04-10 | View → |
| 424B5 | 424B5 | 2026-03-30 | View → |
| 10-K | 10-K | 2026-03-30 | View → |
| 8-K | 8-K | 2026-03-30 | View → |
| 8-K | 8-K | 2026-01-23 | View → |
| 4 | 4 | 2026-01-13 | View → |
| 4 | 4 | 2026-01-13 | View → |
| 4 | 4 | 2026-01-13 | View → |
| 4 | 4 | 2026-01-13 | View → |
| 4 | 4 | 2026-01-13 | View → |
| 4 | 4 | 2025-12-22 | View → |
| 4 | Insider transaction | 2025-12-22 | View → |
| 8-K | 8-K | 2025-11-13 | View → |
| 10-Q | 10-Q | 2025-11-12 | View → |
| 8-K | 8-K | 2025-09-23 | View → |
| 4 | 4 | 2025-09-23 | View → |
| 4 | 4 | 2025-09-23 | View → |
| 4 | 4 | 2025-09-23 | View → |
| 4 | 4 | 2025-09-23 | View → |
| 4 | 4 | 2025-09-23 | View → |
| 4 | 4 | 2025-09-23 | View → |
| 4 | 4 | 2025-08-20 | View → |
| 8-K | 8-K | 2025-08-13 | View → |
| 10-Q | 10-Q | 2025-08-13 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $0.86
- Market Cap
- $12.85 million
- 52-Week Range
- $0.84 – $4.70
- Average Volume
- 246K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.